Last reviewed: May 12, 2026
Last updated: May 12, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Semaglutide, marketed under brand names like Ozempic and Wegovy, is classified as a GLP-1 receptor agonist. GLP-1, or glucagon-like peptide-1, is a hormone that plays a vital role in regulating appetite and blood sugar levels. By mimicking GLP-1, Semaglutide enhances insulin secretion in response to
Mechanism of Action
Semaglutide works by stimulating the GLP-1 receptor, leading to:
- Increased insulin secretion in response to meals.
- Decreased glucagon release, which helps lower blood sugar levels.
- Slowed gastric emptying, which prolongs feelings of fullness.
These actions collectively contribute to reduced appetite and caloric intake, making it easier for individuals to manage their weight.
Tirzepatide takes a more complex approach by activating both GLP-1 and GIP receptors. This dual action results in:
- Enhanced insulin secretion and improved insulin sensitivity.
- Decreased glucagon levels, aiding in blood sugar control.
- Greater appetite suppression due to its effects on both hormone pathways.
Efficacy in Weight Loss
Clinical trials have shown that Semaglutide is effective in promoting weight loss. In a pivotal study, participants using Semaglutide lost an average of 14.9% of their body weight over 68 weeks. This weight loss is significant, especially for individuals with obesity or overweight related health conditions.
Tirzepatide has garnered attention for its remarkable efficacy in weight loss. In the SURMOUNT-1 trial, participants experienced an average weight loss of up to 20.9%, depending on the dosage. This level of weight loss is comparable to results typically seen in surgical interventions, making Tirzepatide a compelling option for those serious about managing their weight.
Side Effects
Both medications share similar side effects, primarily related to the gastrointestinal system. Common side effects of Semaglutide include:
- Nausea
- Vomiting
- Diarrhea
- Constipation
- Abdominal discomfort
While these side effects may be bothersome, they often diminish over time as the body adjusts to the medication.
Tirzepatide exhibits a similar side effect profile but may cause slightly fewer gastrointestinal issues at higher doses compared to Semaglutide. Common side effects include:
- Nausea
- Vomiting
- Diarrhea
- Constipation
- Injection site reactions
Dosing and Administration
Semaglutide is typically initiated at a low dose, such as 0.25 mg per week, gradually increasing to a maintenance dose of up to 2.4 mg per week over a period of several weeks. This titration strategy helps minimize side effects and allows the body to adjust.
Tirzepatide also starts at a low dose, usually 2.5 mg per week, and can be titrated up to a maximum of 15 mg per week, depending on individual response and tolerability. This flexibility allows healthcare providers to tailor the treatment to the patient’s needs.
Choosing the Right Medication
When considering whether Semaglutide or Tirzepatide is the right choice for you, several factors come into play:
-
Medical History: Your healthcare provider will assess your overall health, including any pre-existing conditions that may influence the choice of medication.
-
Weight Loss Goals: If significant weight loss is your primary objective, Tirzepatide may offer a more effective option based on clinical trial outcomes.
-
Side Effect Tolerance: Consider how well you tolerate gastrointestinal side effects, as this may influence your experience with either medication.
Ultimately, a thorough consultation with a healthcare provider is essential to determine the most appropriate treatment based on your unique circumstances.
FAQ
Can I take Semaglutide and Tirzepatide together?
Are there specific health conditions that might prevent me from taking these medications?
How quickly can I expect to see results from these medications?
Do these medications come with any serious health risks?
How do I access Semaglutide or Tirzepatide for weight loss?
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month, or $298 standalone) gives your provider a pharmacogenomic foundation before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Injection starts at $249/mo. Medications are dispensed from 503B-registered outsourcing facilities meeting federal CGMP standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
Can I take Semaglutide and Tirzepatide together?
No, these medications should not be used concurrently. They work on similar pathways and should only be prescribed based on a healthcare provider’s recommendation.
Are there specific health conditions that might prevent me from taking these medications?
Yes, individuals with a history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2 should avoid these medications due to potential risks.
How quickly can I expect to see results from these medications?
Weight loss results can vary, but many individuals start to see changes within the first few weeks of treatment, particularly with Tirzepatide.
Do these medications come with any serious health risks?
Both Semaglutide and Tirzepatide carry warnings regarding potential thyroid tumors, as observed in animal studies. Regular monitoring by a healthcare provider is essential.
How do I access Semaglutide or Tirzepatide for weight loss?
To explore your eligibility for these medications, we encourage you to take PlexusDx's free assessment quiz. PlexusDx's personalized weight loss programs are designed to support you every step of the way.
Related Reading
Pricing and availability current as of May 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Do You Lose More Weight on Semaglutide or Tirzepatide?
Why GLP-1 Medications Cause Fatigue and How to Fix It